terbutaline has been researched along with Cardiotoxicity in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, CL | 1 |
| Coro, M | 1 |
| Cowl, A | 1 |
| Sala, KA | 1 |
| Schramm, CM | 1 |
1 other study available for terbutaline and Cardiotoxicity
| Article | Year |
|---|---|
Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; | 2014 |